ADVANCING CLINICAL TRIALS READINESS (ACTR)
ID: ARPA-H-SN-25-121Type: Special Notice
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNIH ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)Bethesda, MD, 208920004, USA

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)

PSC

HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT (AN13)

Original Source

https://sam.gov/opp/69e3f83e271d47f38da05f792f98b031/view
Timeline
    Description

    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) through the Advanced Research Projects Agency for Health (ARPA-H), is hosting a hybrid Proposers’ Day for the Advancing Clinical Trials Readiness (ACTR) initiative. This event aims to gather insights and proposals that will enhance the readiness of clinical trials, focusing on innovative research and development in the health sector. The ACTR initiative is crucial for improving the efficiency and effectiveness of clinical trials, ultimately contributing to advancements in healthcare solutions. Interested parties can find registration details and additional information at the provided link, and inquiries can be directed to the ACTR Email Box at ACTR@ARPA-H.GOV.

    Point(s) of Contact
    ACTR Email Box
    ACTR@ARPA-H.GOV
    Files
    No associated files provided.
    Lifecycle
    Title
    Type
    ADVANCING CLINICAL TRIALS READINESS (ACTR)
    Currently viewing
    Special Notice
    Similar Opportunities
    ADAPT Contract Research Organization Support Services
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is seeking feedback on a draft solicitation for the ADAPT Contract Research Organization Support Services. This initiative aims to support a clinical trial framework focused on metastatic cancer treatment, utilizing biomarker-driven strategies to enhance patient outcomes. The contract encompasses a range of services, including data management, biological testing, regulatory support, and logistical capabilities, all while adhering to stringent data protection and confidentiality standards. Interested parties are invited to submit unclassified feedback by December 27, 2024, to Steven Snyder at steven.snyder@arpa-h.gov, with the contract performance period anticipated from March 2025 to February 2030.
    Emerging Health Innovators (EHI) Initiative Proposers' Day
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is hosting a virtual Proposers' Day for the Emerging Health Innovators (EHI) Initiative on January 8, 2025. This initiative aims to engage early career investigators and community innovators in advanced health research, with two application tracks: Technology-Driven Innovation for biomedical researchers and Community-Centered Innovation for community innovators, each focusing on innovative health technologies and community health solutions. Proposals may receive funding of up to $350,000 annually for two years, with a potential extension, and interested participants should register by January 6, 2025, to gain insights into funding opportunities and submission guidelines. For further information, potential proposers can contact the EHI Initiative Team at EHI@ARPA-H.gov.
    Computational ADME Tox AnaLYsis for Safer Therapeutics (CATALYST) Innovative Solutions Opening
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Computational ADME Tox AnaLYsis for Safer Therapeutics (CATALYST) Innovative Solutions Opening. This initiative aims to foster innovative research in drug development, specifically focusing on in silico human physiology modeling platforms to enhance drug safety assessments and reduce reliance on animal testing. The program is structured in two phases: Phase I involves developing predictive tools and technologies, while Phase II focuses on their integration into regulatory submissions for IND-enabling studies. Interested parties must submit solution summaries by November 25, 2024, at 5:00 PM ET, and can find more information and submission guidelines on the ARPA-H website or by contacting the CATALYST team via email at CATALYST@arpa-h.gov.
    Office-Wide Innovative Solutions Opening for Proactive Health Office (PHO)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting innovative research proposals aimed at enhancing health outcomes via the Proactive Health Office (PHO). The initiative focuses on developing solutions that prioritize disease prevention, early intervention, and scalable wellness-promoting behaviors, moving away from traditional reactive healthcare models. This opportunity is significant for entities capable of delivering transformative health solutions, with proposals evaluated based on scientific merit and relevance, and funding potentially awarded through Other Transactions or Cooperative Agreements. Interested parties must submit a mandatory solution summary by March 3, 2029, and can direct inquiries to the designated contact via the provided submission platforms.
    ARPA-H PROactive Solutions for Prolonging Resilience (PROSPR) Proposers' Day
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is hosting a Proposers’ Day on January 24, 2025, to discuss the PROactive Solutions for Prolonging Resilience (PROSPR) Program. This initiative aims to develop innovative interventions that extend healthspan by addressing age-related health decline and accelerating the research and development of therapeutics, focusing on three key areas: creating an intrinsic capacity score for health outcomes, repurposing FDA-approved drugs, and advancing preclinical interventions. The event will be held in a hybrid format in Dallas, Texas, and virtually, promoting engagement and collaboration within the research community, with registration required by January 21, 2025. Interested parties can connect with potential collaborators by submitting "teaming profiles" and can reach out to the PROSPR Email Box at PROSPR@arpa-h.gov for further information.
    Office-Wide Innovative Solutions Opening for Health Science Futures (HSF)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Innovative Solutions Opening (ISO) aimed at advancing healthcare technologies. This initiative seeks innovative, disease-agnostic research projects that can significantly improve health outcomes, focusing on areas such as maternal and fetal health, genetic therapies, and novel diagnostic tools. The solicitation emphasizes the development of transformative solutions rather than incremental research, with submissions required to follow a two-step process: an initial solution summary followed by a full proposal based on feedback received. Interested parties must submit their solution summaries by March 3, 2029, via the designated ARPA-H portal, and are encouraged to review the detailed submission guidelines outlined in the provided documentation.
    Office-Wide Innovative Solutions Opening for Scalable Solutions Office (SSO)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting innovative solutions aimed at enhancing healthcare accessibility, affordability, and scalability. This opportunity invites universities, non-profits, small businesses, and similar entities to submit solution summaries and proposals that address health disparities, improve the distribution of healthcare technologies, and advance biomanufacturing innovations. The solicitation emphasizes the development of scalable technologies and collaborative distribution networks, with a focus on interdisciplinary approaches to revolutionize biomedicine and public health outcomes. Interested parties must submit their solution summaries by March 3, 2029, and can find further details and submission guidelines at https://solutions.arpa-h.gov. For inquiries, questions should be directed to the same website.
    Ocular Laboratory for Analysis of Biomarkers (OCULAB)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is announcing a Proposers' Day for the Ocular Laboratory for Analysis of Biomarkers (OCULAB) program. This initiative aims to develop non-invasive diagnostic technologies for ocular and systemic conditions, particularly focusing on dry eye disease, through two primary technical areas: sensor technology for continuous biomarker monitoring and closed-loop therapeutic dosing systems. The Proposers' Day, scheduled for December 12, 2024, in Tampa Bay, Florida, will facilitate collaboration among participants and provide insights into the program's goals, with registration open from October 18, 2024, to December 5, 2024. Interested parties can contact OCULAB@ARPA-H.gov for further information and are encouraged to register for the event to enhance their proposal submissions.
    ARPA-H Rare disease AI/ML for Precision Integrated Diagnostics (RAPID) Proposers' Day
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is hosting a Proposers’ Day for the Rare disease AI/ML for Precision Integrated Diagnostics (RAPID) Program. This event, scheduled for January 23, 2025, in San Francisco and virtually, aims to inform potential proposers about the program's objectives, timelines, and the upcoming Innovative Solutions Opening (ISO), focusing on the development of AI and machine learning diagnostic tools for rare diseases. The RAPID initiative emphasizes the integration of fragmented health data to improve diagnostic capabilities, particularly for underserved populations, and spans a total duration of 4.5 years across two phases. Interested parties can reach out to the RAPID Email Box at RAPID@ARPA-H.gov for further information.
    Office-Wide Innovative Solutions Opening for Resilient Systems Office (RSO)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting innovative solutions aimed at enhancing the resilience of healthcare systems via its Resilient Systems Office (RSO). This opportunity invites submissions from eligible entities, including universities, nonprofits, and small businesses, to address systemic challenges in healthcare and public health by leveraging cutting-edge technologies that improve care quality and availability. The solicitation emphasizes the importance of sociotechnical system innovations and adaptive solutions that enhance the reliability and interoperability of health ecosystems. Interested parties must submit solution summaries for feedback before full proposal submissions, with the solicitation open until March 3, 2029. For further inquiries, submissions should be directed to the designated online platforms, and the primary contact email is provided in the solicitation details.